Notice: This company has been marked as potentially delisted and may not be actively trading. (ANTX) (ANTX) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesTrends ANTX vs. CLYM, NKTX, CKPT, SCPH, VTYX, MCRB, NBTX, PBYI, MNPR, and GALTShould you be buying (ANTX) stock or one of its competitors? The main competitors of (ANTX) include Climb Bio (CLYM), Nkarta (NKTX), Checkpoint Therapeutics (CKPT), scPharmaceuticals (SCPH), Ventyx Biosciences (VTYX), Seres Therapeutics (MCRB), Nanobiotix (NBTX), Puma Biotechnology (PBYI), Monopar Therapeutics (MNPR), and Galectin Therapeutics (GALT). These companies are all part of the "pharmaceutical preparations" industry. (ANTX) vs. Climb Bio Nkarta Checkpoint Therapeutics scPharmaceuticals Ventyx Biosciences Seres Therapeutics Nanobiotix Puma Biotechnology Monopar Therapeutics Galectin Therapeutics (ANTX) (NYSE:ANTX) and Climb Bio (NASDAQ:CLYM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends. Which has more volatility and risk, ANTX or CLYM? (ANTX) has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Climb Bio has a beta of -0.4, meaning that its stock price is 140% less volatile than the S&P 500. Does the MarketBeat Community favor ANTX or CLYM? (ANTX) received 93 more outperform votes than Climb Bio when rated by MarketBeat users. However, 100.00% of users gave Climb Bio an outperform vote while only 58.28% of users gave (ANTX) an outperform vote. CompanyUnderperformOutperform(ANTX)Outperform Votes9558.28% Underperform Votes6841.72% Climb BioOutperform Votes2100.00% Underperform VotesNo Votes Is ANTX or CLYM more profitable? Climb Bio's return on equity of -42.21% beat (ANTX)'s return on equity.Company Net Margins Return on Equity Return on Assets (ANTX)N/A -57.62% -52.08% Climb Bio N/A -42.21%-41.39% Do analysts recommend ANTX or CLYM? (ANTX) currently has a consensus target price of $2.67, indicating a potential upside of 111.64%. Climb Bio has a consensus target price of $10.00, indicating a potential upside of 412.82%. Given Climb Bio's stronger consensus rating and higher possible upside, analysts clearly believe Climb Bio is more favorable than (ANTX).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score (ANTX) 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Climb Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media prefer ANTX or CLYM? In the previous week, Climb Bio had 3 more articles in the media than (ANTX). MarketBeat recorded 3 mentions for Climb Bio and 0 mentions for (ANTX). Climb Bio's average media sentiment score of 0.25 beat (ANTX)'s score of 0.00 indicating that Climb Bio is being referred to more favorably in the news media. Company Overall Sentiment (ANTX) Neutral Climb Bio Neutral Which has stronger earnings & valuation, ANTX or CLYM? Climb Bio is trading at a lower price-to-earnings ratio than (ANTX), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio(ANTX)N/AN/A-$64.73M-$2.04-0.62Climb BioN/AN/A-$35.12M-$2.13-0.92 Do insiders & institutionals have more ownership in ANTX or CLYM? 90.5% of (ANTX) shares are owned by institutional investors. Comparatively, 69.8% of Climb Bio shares are owned by institutional investors. 20.8% of (ANTX) shares are owned by insiders. Comparatively, 3.2% of Climb Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryClimb Bio beats (ANTX) on 9 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get (ANTX) News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANTX vs. The Competition Export to ExcelMetric(ANTX)Pharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$37.65M$6.57B$5.12B$19.18BDividend YieldN/A2.98%4.91%3.59%P/E Ratio-0.6210.5991.3441.28Price / SalesN/A195.381,116.5917.59Price / CashN/A57.1642.6421.28Price / Book0.305.104.795.32Net Income-$64.73M$151.51M$120.07M$989.88M (ANTX) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANTX(ANTX)2.8506 of 5 stars$1.26-0.8%$2.67+111.6%-93.8%$37.65MN/A-0.62N/ACLYMClimb Bio3.3154 of 5 stars$2.47-5.0%$10.00+304.9%N/A$166.04MN/A-1.22N/ANews CoverageNKTXNkarta2.7945 of 5 stars$2.34flat$15.00+541.0%-35.4%$165.13MN/A-1.24140Gap UpCKPTCheckpoint Therapeutics3.8163 of 5 stars$3.37-8.2%$10.33+206.6%+113.1%$164.56M$100,000.00-1.8310Insider TradeNews CoverageGap UpHigh Trading VolumeSCPHscPharmaceuticals3.2494 of 5 stars$3.28+2.8%$15.00+357.3%-43.6%$164.13M$13.59M-1.6830VTYXVentyx Biosciences2.9157 of 5 stars$2.28flat$10.00+338.6%+7.7%$161.22MN/A-0.9773MCRBSeres Therapeutics3.3434 of 5 stars$0.92+5.0%$5.08+451.0%-14.4%$157.51M$126.33M-4.04233NBTXNanobiotix2.0847 of 5 stars$3.34+0.3%$12.00+259.3%-53.3%$157.42M$36.22M0.00100News CoverageGap UpPBYIPuma Biotechnology3.9481 of 5 stars$3.01+4.5%$7.00+132.6%-30.0%$147.76M$243.57M6.42185Positive NewsMNPRMonopar Therapeutics1.9712 of 5 stars$27.06+6.6%$27.33+1.0%+1,165.4%$142.82MN/A-12.8810News CoverageGap UpGALTGalectin Therapeutics1.9706 of 5 stars$2.26+6.9%$11.00+387.8%-39.2%$141.53MN/A-3.149News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies CLYM Competitors NKTX Competitors CKPT Competitors SCPH Competitors VTYX Competitors MCRB Competitors NBTX Competitors PBYI Competitors MNPR Competitors GALT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ANTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ANTX) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ANTX) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANTX Stock Alerts